Article
Challenges to implementation of an epidermal growth factor receptor testing strategy for non-small-cell lung cancer in a publicly funded health care system.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Sept 2013
Ellis Peter M, Verma Sunil, Sehdev Sandeep, Younus Jawaid, Leighl Natasha B
Abstract excerpt
BACKGROUND: Data from seven recent randomized clinical trials have demonstrated that epidermal growth factor (EGFR) mutation status is predictive of improved progression-free survival and quality of life from first-line EGFR tyrosine kinase inhibitor therapy compared with platinum-based chemotherapy. We examined barriers to the initial implementation of a national EGFR testing policy in Canada. METHODS: Five...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.